elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33986172-0638D051-EC47-4D51-9C66-0D9EFF1E37F9
Q33986172-0638D051-EC47-4D51-9C66-0D9EFF1E37F9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33986172-0638D051-EC47-4D51-9C66-0D9EFF1E37F9
Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator.
P2860
Q33986172-0638D051-EC47-4D51-9C66-0D9EFF1E37F9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33986172-0638D051-EC47-4D51-9C66-0D9EFF1E37F9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
91193e8d0e70c1bf2538d32919ae9e02409c176c
P2860
A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.